Literature DB >> 19356679

Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat.

P Liu1, D H Bergin.   

Abstract

Recent evidence suggests that agmatine, the metabolite of arginine by arginine decarboxylase, exists in the mammalian brain and is a novel neurotransmitter. Exogenous agmatine can modulate behaviour function, including learning and memory. The present study investigated the effects of repeated i.c.v. microinfusion of agmatine (once daily) on the reference and working memory versions of the water maze task, as well as the elevated plus maze and open field. Rats with high (100 microg), but not low (10 microg), dose of agmatine displayed reduced exploratory and locomotor activity in the open field relative to the saline controls on day 1 (received three infusions), but not day 12 (received 14 infusions). The three groups performed similarly on both days in the elevated plus maze tested prior to the open field. In the reference memory version of the water maze task, rats with agmatine treatment at both doses performed as well as the saline controls in the cued navigation (day 2), place navigation (days 3-7) and probe test (day 7). In the working memory version of the water maze task (days 8-11), the two agmatine groups generated markedly shorter path length and took significantly less time to reach the platform at the 180 s, but not 30 s, delay as compared to the saline group. These results demonstrate that repeated agmatine treatment produces transient impairments in exploratory and locomotor activity in the open field in a dose-dependent manner. Agmatine significantly facilitates spatial working memory at a longer delay, but not reference memory, suggesting its differential influence on the two types of spatial learning and memory. The underlying mechanisms need to be explored in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356679     DOI: 10.1016/j.neuroscience.2009.01.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Interactions of nitric oxide with α2 -adrenoceptors within the locus coeruleus underlie the facilitation of inhibitory avoidance memory by agmatine.

Authors:  Gajanan P Shelkar; Sukanya G Gakare; Suwarna Chakraborty; Shashank M Dravid; Rajesh R Ugale
Journal:  Br J Pharmacol       Date:  2016-08-01       Impact factor: 8.739

2.  Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.

Authors:  B G Taksande; N R Kotagale; K T Nakhate; P D Mali; D M Kokare; K Hirani; N K Subhedar; C T Chopde; R R Ugale
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage.

Authors:  John E Piletz; Stephanie Klenotich; Ken S Lee; Qian Long Zhu; Edward Valente; Michael A Collins; Vyvyca Jones; Soeb Nam Lee; Feng Yangzheng
Journal:  Neurotox Res       Date:  2013-01-19       Impact factor: 3.911

4.  Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model.

Authors:  Juhyun Song; Bo Eun Hur; Kiran Kumar Bokara; Wonsuk Yang; Hyun Jin Cho; Kyung Ah Park; Won Taek Lee; Kyoung Min Lee; Jong Eun Lee
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

5.  Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

Authors:  D H Bergin; Y Jing; B G Mockett; H Zhang; W C Abraham; P Liu
Journal:  Transl Psychiatry       Date:  2018-05-25       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.